C. Perret et al., MALONDIALDEHYDE DOSIMETRY IN LASER-IRRADIATED TISSUES SENSITIZED BY HEMATOPORPHYRIN DERIVATIVE, The Journal of pharmacology and experimental therapeutics, 269(2), 1994, pp. 787-791
Photodynamic therapy (PDT) is based on the selective retention of a ph
otosensitizer (hematoporphyrin derivative [HPD]) by tumor tissue and t
he subsequent irradiation of this tissue with light. Unsaturated phosp
holipids are important targets of membrane photodamage, and malondiald
ehyde (MDA), an ultimate marker of lipid peroxidation, can easily be m
easured by the fluorometric thiobarbituric acid (TBA) assay. To determ
ine whether MDA content represents a reference for PDT intensity, tiss
ue content in 7-week-old male nude mice was studied on biopsy samples
after PDT (5 mg/kg HPD injected intravenously 24 hr before irradiation
at 632 nm) with or without intraperitoneal injection of WR-2721 40 mi
n before treatment. The FeCl3 method requiring only 15 min of incubati
on in a 95 degrees C waterbath proved most effective compared with the
method involving phosphotungstic acid or the MDA-TBA determination us
ing a commercially available kit. Whatever the method used, the best r
esults were found using a 60-min interval between treatment and freezi
ng. MDA concentration in HPD-PDT-treated samples was significantly hig
her than in HPD-tested controls (P <.01) and increased at laser irradi
ation doses ranging from 0 to 50 J/cm(2). Administration of WR-2721 in
traperitoneally significantly reduced MDA concentration (from 70% to 3
8%). A maximal effect was obtained with 100 mg/kg for brain (-70%) and
200 mg/kg for muscle (-47%). Higher doses produced no additional chan
ges. The MDA assay is a simple tool for indirect evaluation of PDT, an
d WR-2721 can decrease MDA content in normal tissue, suggesting the po
ssibility of good protection for normal tissue during PDT.